• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用放射性同位素交换-高效液相色谱法通过血浆和血斑的酰基肉碱分析检测脂肪酸氧化先天性代谢缺陷。

Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method.

作者信息

Schmidt-Sommerfeld E, Penn D, Duran M, Bennett M J, Santer R, Stanley C A

机构信息

Department of Pediatrics, University of Chicago, Illinois.

出版信息

J Pediatr. 1993 May;122(5 Pt 1):708-14. doi: 10.1016/s0022-3476(06)80009-0.

DOI:10.1016/s0022-3476(06)80009-0
PMID:8496747
Abstract

Sixty-one plasma samples from patients with inborn errors of fatty acid oxidation and from control subjects were analyzed in a blinded fashion for acylcarnitines by the radioisotopic exchange-high-performance liquid chromatographic method. All samples from patients with medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency (n = 30), some of which had been stored in a frozen state for several years, showed a prominent octanoylcarnitine peak. In all blood spots from 11 patients with MCAD deficiency, octanoylcarnitine was also detected. Control plasma specimens and blood spots contained small amounts of octanoylcarnitine; however, the octanoylcarnitine/acetylcarnitine ratio differentiated patients with MCAD deficiency. Longer-chain acylcarnitines were found in plasma of all three patients with defects in long-chain fatty acid oxidation. Plasma and blood spots from a patient with multiple acyl-coenzyme A dehydrogenase deficiency contained C4-acylcarnitine, hexanoylcarnitine, octanoylcarnitine, and decanoylcarnitine. The results suggest that the method may be highly sensitive in detecting MCAD deficiency and other defects in fatty acid oxidation from plasma or blood spots.

摘要

采用放射性同位素交换-高效液相色谱法,对61份来自脂肪酸氧化先天性代谢缺陷患者和对照受试者的血浆样本进行酰基肉碱分析,分析过程采用盲法。所有来自中链酰基辅酶A脱氢酶(MCAD)缺乏症患者的样本(n = 30),其中一些已冷冻保存数年,均显示出明显的辛酰肉碱峰。在11例MCAD缺乏症患者的所有血斑中,也检测到了辛酰肉碱。对照血浆标本和血斑中含有少量辛酰肉碱;然而,辛酰肉碱/乙酰肉碱比值可区分MCAD缺乏症患者。在所有3例长链脂肪酸氧化缺陷患者的血浆中均发现了长链酰基肉碱。一名多种酰基辅酶A脱氢酶缺乏症患者的血浆和血斑中含有C4-酰基肉碱、己酰肉碱、辛酰肉碱和癸酰肉碱。结果表明,该方法在检测血浆或血斑中的MCAD缺乏症和其他脂肪酸氧化缺陷方面可能具有高度敏感性。

相似文献

1
Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method.采用放射性同位素交换-高效液相色谱法通过血浆和血斑的酰基肉碱分析检测脂肪酸氧化先天性代谢缺陷。
J Pediatr. 1993 May;122(5 Pt 1):708-14. doi: 10.1016/s0022-3476(06)80009-0.
2
Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.中链酰基辅酶A脱氢酶缺乏症、中链甘油三酯喂养及丙戊酸治疗中的尿中链酰基肉碱:放射性同位素交换/高效液相色谱法的敏感性和特异性
Pediatr Res. 1992 Jun;31(6):545-51. doi: 10.1203/00006450-199206000-00002.
3
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.中链酰基辅酶A脱氢酶(MCAD)缺乏症:通过血液中酰基肉碱分析进行诊断。
Am J Hum Genet. 1993 May;52(5):958-66.
4
A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.一种使用未标记棕榈酸对人皮肤成纤维细胞进行定量酰基肉碱谱分析的方法:脂肪酸氧化障碍的诊断及中链酰基辅酶A脱氢酶缺乏症生化表型的鉴别
Biochim Biophys Acta. 2002 Oct 10;1584(2-3):91-8. doi: 10.1016/s1388-1981(02)00296-2.
5
Detection and quantitation of acylcarnitines in plasma and blood spots from patients with inborn errors of fatty acid oxidation.对脂肪酸氧化先天性代谢缺陷患者血浆和血斑中酰基肉碱的检测与定量分析。
Prog Clin Biol Res. 1992;375:355-62.
6
MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment.
Adv Exp Med Biol. 1999;466:353-63.
7
Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.中链酰基辅酶A脱氢酶缺乏症患者尿中肉碱酯的定量分析:代谢状态和L-肉碱治疗的影响
J Pediatr. 1989 Oct;115(4):577-82. doi: 10.1016/s0022-3476(89)80284-7.
8
Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: monitoring of treatment by carnitine/acylcarnitine analysis in blood spots.
Acta Paediatr. 2000 Apr;89(4):492-5. doi: 10.1080/080352500750028267.
9
Prenatal diagnosis of mitochondrial fatty acid oxidation defects.线粒体脂肪酸氧化缺陷的产前诊断
Prenat Diagn. 1996 Feb;16(2):117-24. doi: 10.1002/(SICI)1097-0223(199602)16:2<117::AID-PD820>3.0.CO;2-Z.
10
Differences between acylcarnitine profiles in plasma and bloodspots.血浆和血斑中酰基肉碱谱的差异。
Mol Genet Metab. 2013 Sep-Oct;110(1-2):116-21. doi: 10.1016/j.ymgme.2013.04.008. Epub 2013 Apr 13.

引用本文的文献

1
Tandem Mass Spectrometry for the Analysis of Plasma/Serum Acylcarnitines for the Diagnosis of Certain Organic Acidurias and Fatty Acid Oxidation Disorders.串联质谱法分析血浆/血清酰基肉碱用于某些有机酸血症和脂肪酸氧化障碍的诊断。
Methods Mol Biol. 2022;2546:27-34. doi: 10.1007/978-1-0716-2565-1_3.
2
Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.基于 LC-HRMS 和 PLS-DA 的人肾透明细胞癌组织和尿液代谢组学研究。
Anal Bioanal Chem. 2018 Jun;410(16):3859-3869. doi: 10.1007/s00216-018-1059-x. Epub 2018 Apr 16.
3
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
肉碱及酰基肉碱:药代动力学、药理学和临床方面。
Clin Pharmacokinet. 2012 Sep 1;51(9):553-72. doi: 10.1007/BF03261931.
4
Pharmacokinetics of L-carnitine.左旋肉碱的药代动力学
Clin Pharmacokinet. 2003;42(11):941-67. doi: 10.2165/00003088-200342110-00002.
5
Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency.患有长链3-羟基酰基辅酶A脱氢酶缺乏症患者血浆和血斑中的酰基肉碱
J Inherit Metab Dis. 2000 Sep;23(6):571-82. doi: 10.1023/a:1005673828469.
6
Disorders of mitochondrial fatty acyl-CoA beta-oxidation.线粒体脂肪酰辅酶Aβ氧化紊乱
J Inherit Metab Dis. 1999 Jun;22(4):442-87. doi: 10.1023/a:1005504223140.